Jenkins R L, Fairchild R B
Harvard Medical School, Boston, Massachusetts.
Surg Clin North Am. 1989 Apr;69(2):371-82. doi: 10.1016/s0039-6109(16)44792-4.
Liver transplantation is rapidly emerging as the most effective treatment pathway for a growing number of acute and chronic liver disease states. Indications and contraindications to transplant are undergoing continuous revision and clarification as experience is accrued in the expanding number of treatment centers. For some disorders such as primary biliary cirrhosis, sclerosing cholangitis, and chronic active hepatitis with cirrhosis, the role of transplantation in patient management is obvious. For other hepatic diseases such as primary hepatic neoplasm, clear definition of the role of transplantation is likely to await development of improved early diagnostic techniques and more effective chemotherapy regimens. Standardization of the technical aspects of liver transplant and recent advances in graft preservation have led to reduction in the logistical problems that previously plagued this complex therapy. Refinements in immunosuppression with the introduction of cyclosporine and monoclonal antibody therapy have extended chances for survival and contributed to considerable improvement in quality of life following transplant. Further extension of transplantation as a treatment option to individuals with liver disease will require the concerned effort of the primary care or referral physician in the early recognition and management of patients with liver disease.
肝移植正迅速成为越来越多急慢性肝病最有效的治疗途径。随着越来越多治疗中心积累了经验,移植的适应证和禁忌证正在不断修订和明确。对于某些疾病,如原发性胆汁性肝硬化、硬化性胆管炎和伴有肝硬化的慢性活动性肝炎,移植在患者管理中的作用是显而易见的。对于其他肝脏疾病,如原发性肝脏肿瘤,移植作用的明确定义可能有待于改进的早期诊断技术和更有效的化疗方案的发展。肝移植技术方面的标准化以及移植物保存的最新进展,减少了以前困扰这种复杂治疗的后勤问题。随着环孢素和单克隆抗体疗法的引入,免疫抑制的改进延长了生存机会,并极大地改善了移植后患者的生活质量。将移植作为肝病患者的一种治疗选择进一步推广,将需要初级保健医生或转诊医生在肝病患者的早期识别和管理方面付出努力。